Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chase Pharmaceuticals Corp.

Division of Allergan PLC
www.chasepharmaceuticals.com

Latest From Chase Pharmaceuticals Corp.

Boost For European Biotech As €345m Fund Opens

Edmond De Rothschild Investment Partners unveils the largest life science and medical device venture fund to be raised in Europe. Olivier Litzka tells Scrip that the continent can now boast a public market machinery that contributes to potentially lucrative exits for investors.

Financing StartUps and SMEs

Deal Watch: AstraZeneca Offloads US Anesthesiology Portfolio To Aspen

Merck adds to its immuno-oncology R&D heft with purchase of Rigontec, while Allergan will collaborate with Lyndra to produce once-weekly drugs for Alzheimer’s disease.

Deals M & A

Appointments: Sanofi, Fosun Kite, Milestone, Tocagen, GW Pharma, Hookipa and Bone Therapeutics

This week’s round-up includes the appointment of independent directors by Sanofi’s board of directors, CEO appointments by Fosun Kite Biotechnology and Milestone Pharmaceuticals as well as executive appointments by Tocagen, GW Pharmaceuticals, Bone Therapeutics and Tris Pharma.

Appointments BioPharmaceutical

Biopharma Quarterly Dealmaking Statistics, Q4 2016

Biopharma companies closed out 2016 with $9.6 billion in financing, the strongest quarter of the year. M&A deals reached $12.2 billion in value, led by Lonza's takeover of Capsugel; most of the fourth quarter's largest partnerships were built around innovative platforms in antibodies, peptides and gene therapy.

BioPharmaceutical Deals
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
      • Transdermal
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Allergan PLC
  • Senior Management
  • Thomas N Chase, MD, CSO
    Kathleen Clarence-Smith, MD, PhD, CMO
    Gary Charbonneau, SVP, Reg. Affairs & Operations
  • Contact Info
  • Chase Pharmaceuticals Corp.
    Phone: (202) 223-7002
    1825 K St.
    NW Ste. 520
    Washington, DC 20006
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register